Colorectal cancer surgery has moved beyond an era in which progress was measured almost exclusively by the ability to perform a safe resection. Contemporary surgical quality is now defined by a broader and more demanding framework: oncological radicality, preservation of function, prevention of complications, perioperative recovery, pathological accuracy, survivorship, cost-effectiveness, and -above all -the capacity to individualize treatment. This Research Topic captures that transition. The included contributions do not simply describe isolated technical refinements; collectively, they show how colorectal cancer surgery is becoming an integrated pathway in which operative technique, perioperative optimization, risk prediction, pathology, nursing care, reconstruction, and long-term functional recovery are increasingly interconnected. A purely descriptive summary of the articles would underestimate the value of the collection.Across the 21 contributions, five major areas emerge: oncological quality and staging, technology-enabled surgical precision, prediction and mitigation of perioperative risk, optimization of recovery through ERAS and prehabilitation, and patient-centered survivorship. These areas are not separate, but represent different expressions of the same evolution: from procedure-centered colorectal surgery to personalized colorectal cancer care.The first thematic area concerns oncological adequacy. Lymph node retrieval, D3 dissection, fluorescence guidance, and pathological processing are presented in the collection not as isolated technical endpoints, but as determinants of staging quality and treatment planning [1,2,3,4].The studies addressing lymph node yield emphasize that the traditional threshold of 12 nodes remains clinically important, but also imperfect. It is affected by patient factors, tumor stage, neoadjuvant therapy, anatomical complexity, surgical dissection, and the methodology of pathological examination [1,2]. Therefore, lymph node count should be interpreted as a multidisciplinary quality indicator rather than as a simple surrogate of surgical performance. This concept is strengthened by the work on fluorescence-guided surgery and right-sided D3 lymphadenectomy [3,4]. Indocyanine green may support intraoperative lymphatic mapping and perfusion assessment, while a more extended medial boundary for D3 dissection may increase nodal yield. However, the collection also reminds us that greater visualization or wider dissection must ultimately be judged against clinically meaningful outcomes: margin status, recurrence, survival, morbidity, and value. The challenge for future research is not merely to demonstrate that more nodes can be retrieved, but to clarify when additional staging information changes adjuvant treatment, follow-up intensity, or survival.A second major theme is the evaluation of surgical innovation. The studies on intracorporeal anastomotic configuration, robotic proctectomy, robotic platform evolution, robotic intersphincteric resection, and robotic versus laparoscopic colorectal surgery converge on a cautious but important conclusion: innovation should be assessed according to indication, anatomy, complexity, learning curve, and patient-centered benefit rather than by technological enthusiasm alone [5,6,7,8,9].The comparison between overlap and pi-shaped ileotransverse anastomosis in laparoscopic right hemicolectomy illustrates this principle well [5]. A reconstruction technique may improve operative efficiency, inflammatory response, bowel recovery, and tolerance of oral intake without necessarily proving superiority for anastomotic leakage, particularly when event rates are low and statistical power is limited. The robotic studies add further nuance [6,7,8,9]. Robotic surgery may offer advantages in selected rectal cancer scenarios, especially in the low pelvis, where access, visualization, instrument articulation, and precision may affect circumferential margin status, mesorectal integrity, sphincter preservation, and functional outcomes. At the same time, the collection shows that robotics is not automatically superior to laparoscopy in all patients. Longer operative time, increased costs, platform-specific performance, and institutional experience remain critical variables. The evolution from Si to Xi platforms demonstrates that 'robotic surgery' is not a fixed exposure; it changes with technology, docking efficiency, team familiarity, and case selection [7]. Future comparative studies should therefore avoid simplistic robotic-versus-laparoscopic framing and instead identify the patient, tumor, and system-level contexts in which robotic surgery definitely provides real incremental value.The third thematic area is perioperative risk. Several contributions focus on anastomotic fistula, moderate-to-severe complications after primary tumor resection in metastatic colorectal cancer, experimental effects of 5-fluorouracil on anastomotic integrity, parastomal hernia, and complex pelvic reconstruction [10,11,12,16,17]. Their common message is that postoperative complications should not be regarded as unpredictable events occurring after the operation; instead, they should be anticipated, modeled, and, where possible, modified before and during surgery.Prediction models for anastomotic fistula and postoperative complications are particularly relevant in this respect [10,12]. Variables such as tumor location and stage, operative duration, albumin level, and patient-related characteristics represent modifiable or actionable domains that may influence nutritional optimization, diversion strategy, operative planning, postoperative surveillance, and informed consent. Similarly, the experimental meta-analysis on 5-fluorouracil and anastomotic healing highlights the biological dimension of anastomotic safety [11]. Although animal data cannot directly dictate clinical practice, they help frame anastomotic leakage as a biological and mechanical event...